iothalamic acid has been researched along with tolvaptan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czerwiec, FS; Glockner, J; Hogan, MC; Irazabal, MV; King, BF; Krasa, HB; Ofstie, TG; Ouyang, J; Torres, VE | 1 |
1 trial(s) available for iothalamic acid and tolvaptan
Article | Year |
---|---|
Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Contrast Media; Creatinine; Diuresis; Female; Glomerular Filtration Rate; Hormone Antagonists; Humans; Iothalamic Acid; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Minnesota; Organ Size; p-Aminohippuric Acid; Polycystic Kidney, Autosomal Dominant; Potassium; Receptors, Vasopressin; Renal Circulation; Time Factors; Tolvaptan; Treatment Outcome; Uric Acid | 2011 |